BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 35059996)

  • 21. Neuroendocrine neoplasms of the stomach.
    Louthan O
    Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014 Sep; 158(3):455-60. PubMed ID: 23817299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is local excision sufficient in selected grade 1 or 2 type III gastric neuroendocrine neoplasms?
    Exarchou K; Kamieniarz L; Tsoli M; Victor A; Oleinikov K; Khan MS; Srirajaskanthan R; Mandair D; Grozinsky-Glasberg S; Kaltsas G; Howes N; Pritchard DM; Toumpanakis C
    Endocrine; 2021 Nov; 74(2):421-429. PubMed ID: 34120313
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Gastric Neuroendocrine Tumors (Carcinoids).
    Gluckman CR; Metz DC
    Curr Gastroenterol Rep; 2019 Mar; 21(4):13. PubMed ID: 30868284
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gastroduodenal neuroendocrine neoplasms, including gastrinoma - management guidelines (recommended by the Polish Network of Neuroendocrine Tumours).
    Lipiński M; Rydzewska G; Foltyn W; Andrysiak-Mamos E; Bałdys-Waligórska A; Bednarczuk T; Blicharz-Dorniak J; Bolanowski M; Boratyn-Nowicka A; Borowska M; Cichocki A; Ćwikła JB; Falconi M; Handkiewicz-Junak D; Hubalewska-Dydejczyk A; Jarząb B; Junik R; Kajdaniuk D; Kamiński G; Kolasińska-Ćwikła A; Kowalska A; Król R; Królicki L; Kunikowska J; Kuśnierz K; Lampe P; Lange D; Lewczuk-Myślicka A; Lewiński A; Londzin-Olesik M; Marek B; Nasierowska-Guttmejer A; Nowakowska-Duława E; Pilch-Kowalczyk J; Poczkaj K; Rosiek V; Ruchała M; Siemińska L; Sowa-Staszczak A; Starzyńska T; Steinhof-Radwańska K; Strzelczyk J; Sworczak K; Syrenicz A; Szawłowski A; Szczepkowski M; Wachuła E; Zajęcki W; Zemczak A; Zgliczyński W; Kos-Kudła B
    Endokrynol Pol; 2017; 68(2):138-153. PubMed ID: 28540972
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of immunotherapy in gastro-enteropancreatic neuroendocrine neoplasms (gep-nens): Current advances and future directions.
    Fang L; Arvind D; Dowlati A; Mohamed A
    J Neuroendocrinol; 2021 Mar; 33(3):e12943. PubMed ID: 33724586
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advances in Endoscopic Diagnosis and Treatment of Gastric Neuroendocrine Neoplasms.
    Guo X; Zhao X; Huang G; Yu Y
    Dig Dis Sci; 2024 Jan; 69(1):27-35. PubMed ID: 37971578
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Netazepide, a gastrin receptor antagonist, normalises tumour biomarkers and causes regression of type 1 gastric neuroendocrine tumours in a nonrandomised trial of patients with chronic atrophic gastritis.
    Moore AR; Boyce M; Steele IA; Campbell F; Varro A; Pritchard DM
    PLoS One; 2013; 8(10):e76462. PubMed ID: 24098507
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gastric neuroendocrine neoplasms and related precursor lesions.
    La Rosa S; Vanoli A
    J Clin Pathol; 2014 Nov; 67(11):938-48. PubMed ID: 25053544
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Endoscopic techniques for gastric neuroendocrine tumors: An update.
    Massironi S; Gallo C; Laffusa A; Ciuffini C; Conti CB; Barbaro F; Boskoski I; Dinelli ME; Invernizzi P
    World J Gastrointest Endosc; 2023 Mar; 15(3):103-113. PubMed ID: 37034968
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Inherited tumor syndromes of gastroenteropancreatic and thoracic neuroendocrine neoplasms].
    Couvelard A; Scoazec JY
    Ann Pathol; 2020 Apr; 40(2):120-133. PubMed ID: 32035641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Current concepts in the diagnosis and management of type 1 gastric neuroendocrine neoplasms.
    Kaltsas G; Grozinsky-Glasberg S; Alexandraki KI; Thomas D; Tsolakis AV; Gross D; Grossman AB
    Clin Endocrinol (Oxf); 2014 Aug; 81(2):157-68. PubMed ID: 24750249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinicopathological features and prognosis of gastroenteropancreatic neuroendocrine neoplasms in a Chinese population: a large, retrospective single-centre study.
    Zhang M; Zhao P; Shi X; Zhao A; Zhang L; Zhou L
    BMC Endocr Disord; 2017 Jul; 17(1):39. PubMed ID: 28705205
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of advanced gastroenteropancreatic neuroendocrine neoplasia, are we on the way to personalised medicine?
    Rinke A; Auernhammer CJ; Bodei L; Kidd M; Krug S; Lawlor R; Marinoni I; Perren A; Scarpa A; Sorbye H; Pavel ME; Weber MM; Modlin I; Gress TM
    Gut; 2021 Sep; 70(9):1768-1781. PubMed ID: 33692095
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Are patients with autoimmune thyroid disease and autoimmune gastritis at risk of gastric neuroendocrine neoplasms type 1?
    Alexandraki KI; Nikolaou A; Thomas D; Syriou V; Korkolopoulou P; Sougioultzis S; Kaltsas G
    Clin Endocrinol (Oxf); 2014 May; 80(5):685-90. PubMed ID: 24118101
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Subtype classification and clinicopathological characteristics of gastric neuroendocrine neoplasms: an analysis of 241 cases].
    Zhang P; Zhang Y; Zhang C; Shi Y; Liu J; Liu Q; Yu L; Wang M; Zou G; Lou J; Chen J; Tan H
    Zhonghua Wei Chang Wai Ke Za Zhi; 2016 Nov; 19(11):1241-1246. PubMed ID: 27928793
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Gastric neuroendocrine tumours.
    Crosby DA; Donohoe CL; Fitzgerald L; Muldoon C; Hayes B; O'Toole D; Reynolds JV
    Dig Surg; 2012; 29(4):331-48. PubMed ID: 23075625
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gastric neuroendocrine tumour, atrophic gastritis and autoimmune haemolytic anaemia: a case report and review.
    Papakonstantinou IP; Karakousis ND; Andreadis EA
    Scott Med J; 2019 Nov; 64(4):154-158. PubMed ID: 31403382
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neuroendocrine Tumors: a Relevant Clinical Update.
    Rizen EN; Phan AT
    Curr Oncol Rep; 2022 Jun; 24(6):703-714. PubMed ID: 35254612
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long Non-coding RNAs in Pulmonary Neuroendocrine Neoplasms.
    Narayanan D; Mandal R; Hardin H; Chanana V; Schwalbe M; Rosenbaum J; Buehler D; Lloyd RV
    Endocr Pathol; 2020 Sep; 31(3):254-263. PubMed ID: 32388776
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Recurrent gastric amphicrine tumor with neuroendocrine and pancreatic acinar cell differentiation and somatic MEN1 inactivation arisen during immunotherapy.
    Mastrosimini MG; Mafficini A; Tondulli L; Milella M; Piccoli P; Mattiolo P; Fassan M; Hong SM; Scarpa A; Luchini C
    Virchows Arch; 2023 Sep; 483(3):415-419. PubMed ID: 37581694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.